Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron-Reference-Cited by-同舟云学术

Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron

Published:2008-12 Issue:6 Volume:64 Page:707-713
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Hammond Kathryn E.,Metcalf Meredith,Carvajal Lucas,Okuda Darin T.,Srinivasan Radhika,Vigneron Dan,Nelson Sarah J.,Pelletier Daniel

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ana.21582/fullpdf

Reference44 articles.

1. The non-haemin iron in the cerebral cortex in Alzheimer's disease;Hallgren;J Neurochem,1960

2. Iron deposits in multiple sclerosis and Alzheimer's disease brains;LeVine;Brain Res,1997

3. MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease;Chen;AJNR Am J Neuroradiol,1993

4. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia;Dexter;Brain,1991

5. Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content?;Drayer;AJR Am J Roentgenol,1987

Cited by 243 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Longitudinal myelin content measures of slowly expanding lesions using 7T MRI in multiple sclerosis;Journal of Neuroimaging;2024-05-22

2. The T1-dark-rim: A novel imaging sign for detecting smoldering inflammation in multiple sclerosis;European Journal of Radiology;2024-04

3. The diagnostic value of the central vein sign in radiologically isolated syndrome;Annals of Clinical and Translational Neurology;2024-01-08

4. The T1-dark-rim: A novel imaging sign for detecting smoldering inflammation in multiple sclerosis;2023-11-10

5. Iron in multiple sclerosis – Neuropathology, immunology, and real-world considerations;Multiple Sclerosis and Related Disorders;2023-10